177 related articles for article (PubMed ID: 10740161)
1. Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease.
Redberg RF; Nishino M; McElhinney DB; Dae MW; Botvinick EH
Am Heart J; 2000 Apr; 139(4):739-44. PubMed ID: 10740161
[TBL] [Abstract][Full Text] [Related]
2. Maximal and submaximal aerobic fitness in postmenopausal women: influence of hormone-replacement therapy.
Stathokostas L; Kowalchuk JM; Petrella RJ; Paterson DH
Appl Physiol Nutr Metab; 2008 Oct; 33(5):922-8. PubMed ID: 18923567
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration.
Campisi R; Nathan L; Pampaloni MH; Schöder H; Sayre JW; Chaudhuri G; Schelbert HR
Circulation; 2002 Jan; 105(4):425-30. PubMed ID: 11815423
[TBL] [Abstract][Full Text] [Related]
5. Absence of effects of short-term estrogen replacement therapy on resting and exertional QT and QTc dispersion in postmenopausal women with coronary artery disease.
Sbarouni E; Zarvalis E; Kyriakides ZS; Kremastinos DT
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2392-5. PubMed ID: 9825354
[TBL] [Abstract][Full Text] [Related]
6. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
Grodstein F; Manson JE; Colditz GA; Willett WC; Speizer FE; Stampfer MJ
Ann Intern Med; 2000 Dec; 133(12):933-41. PubMed ID: 11119394
[TBL] [Abstract][Full Text] [Related]
7. Associations of hormone replacement therapy with bone structure and physical performance among postmenopausal women.
Uusi-Rasi K; Beck TJ; Sievänen H; Heinonen A; Vuori I
Bone; 2003 Jun; 32(6):704-10. PubMed ID: 12810178
[TBL] [Abstract][Full Text] [Related]
8. Moderate and heavy oxygen uptake kinetics in postmenopausal women.
Stathokostas L; Kowalchuk JM; Petrella RJ; Paterson DH
Appl Physiol Nutr Metab; 2009 Dec; 34(6):1065-72. PubMed ID: 20029515
[TBL] [Abstract][Full Text] [Related]
9. Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women.
Moreau KL; Donato AJ; Seals DR; DeSouza CA; Tanaka H
Cardiovasc Res; 2003 Mar; 57(3):861-8. PubMed ID: 12618248
[TBL] [Abstract][Full Text] [Related]
10. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement and exercise capacity in postmenopausal women: a randomized placebo-controlled study.
Aldrighi JM; Calvoso-Júnior R; Alecrin IN; Trombetta IC; Negrão CE
Gynecol Endocrinol; 2005 Dec; 21(6):324-9. PubMed ID: 16390780
[TBL] [Abstract][Full Text] [Related]
12. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
McPherson R
Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
[TBL] [Abstract][Full Text] [Related]
13. Plasma fibrinogen levels in healthy postmenopausal women: physical activity and hormone replacement status.
DeSouza CA; Stevenson ET; Davy KP; Jones PP; Seals DR
J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M294-8. PubMed ID: 9310083
[TBL] [Abstract][Full Text] [Related]
14. Physical activity, hormone replacement therapy, and the presence of coronary calcium in midlife women.
Weinberg N; Young A; Hunter CJ; Agrawal N; Mao S; Budoff MJ
Women Health; 2012; 52(5):423-36. PubMed ID: 22747181
[TBL] [Abstract][Full Text] [Related]
15. Oral estrogen therapy may mitigate the effects of aerobic training on cardiorespiratory fitness in postmenopausal women: a double-blind, randomized clinical pilot study.
Cardoso CG; Medina FL; Pinto LG; Oneda B; Costa LA; Labes E; Abrahão SB; Tinucci T; Mion D; Fonseca AM; de Moraes Forjaz CL
Menopause; 2014 Apr; 21(4):376-82. PubMed ID: 23942244
[TBL] [Abstract][Full Text] [Related]
16. Does hormone replacement therapy inhibit coronary artery calcification?
Shemesh J; Frenkel Y; Leibovitch L; Grossman E; Pines A; Motro M
Obstet Gynecol; 1997 Jun; 89(6):989-92. PubMed ID: 9170479
[TBL] [Abstract][Full Text] [Related]
17. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function.
Sorensen KE; Dorup I; Hermann AP; Mosekilde L
Circulation; 1998 Apr; 97(13):1234-8. PubMed ID: 9570192
[TBL] [Abstract][Full Text] [Related]
18. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
[TBL] [Abstract][Full Text] [Related]
19. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
[TBL] [Abstract][Full Text] [Related]
20. Effect of age on the exercise response in normal postmenopausal women during estrogen replacement therapy.
Seminario NA; Sciacca RR; DiTullio MR; Homma S; Giardina EG
J Womens Health Gend Based Med; 1999 Dec; 8(10):1273-9. PubMed ID: 10643835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
